Local News: Eldorado, OH 

 | 

Sign Up

 | 

Sign In

Advertisment

Enbrel, Etanercept

Enbrel, Etanercept Wire

Comprehensive News Feed for Enbrel, Etanercept (generic).

Results 1 - 20 of 231 in Enbrel, Etanercept (generic)

  1. Survey shows majority of rheumatologists would prescribe Actemra drug for rheumatoid arthritis

    17 hrs ago | Medical News

    Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.

    Comment?

    Related Topix: Rheumatoid Arthritis, Medicine, Arthritis, Health, Biotech, Healthcare Industry, Tnf, Medication

  2. Decision Resources: Biosimilars may cause biotech companies to lose more than $9 billionRead the original story

    18 hrs ago | Drug Store News

    WALTHAM,A Mass. Biotech companies that manufacture a class of drugs used to treat autoimmune disorders stand to lose more than $9 billion in Europe and the United States by 2018 thanks to competition from biosimilars, according to a report.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Tnf, Health, Medication

  3. Arthritis Drugs Unlikely to Increase Cancer RiskRead the original story w/Photo

    Monday Nov 9 | Mental Help Net

    Rheumatoid arthritis patients who start taking anti-tumor necrosis factor I drugs are not likely to have a higher risk of developing cancer than other groups of RA patients, according to a Swedish study in the November issue of Arthritis & Rheumatism .

    Comment?

    Related Topix: Medicine, Arthritis, Health, Rheumatoid Arthritis, Sweden, Stockholms, Sweden, Stockholm, Sweden, World News

  4. TNF-alpha inhibitors ranked top for reducing biologics spendRead the original story

    Wednesday Nov 4 | News-Medical.Net

    Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor -alpha inhibitors stand to erode $9.6 billion in brand sales in the U.S. and Europe by 2018.

    Comment?

    Related Topix: Tnf, Medicine, Health, Biotech, Healthcare Industry, Medication

  5. Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel,...Read the original story

    Aug 30, 2009 | Drugs.com

    Tumor Necrosis Factor Blockers August 2009 August 31, 2009 Audience: Rheumatologists, gastroenterologists, oncologists, dermatologists [UPDATED 08/31/2009] Supplemental Q&As added [Posted 08/04/2009] FDA notified healthcare professionals that it has completed its analysis of tumor necrosis factor blockers and has concluded that there is an ...

    Comment?

    Related Topix: Tnf, Medicine, Medication, Oncology

  6. TNF Blockers Do Not Increase Cancer Risk in Rheumatoid Arthritis Patients

    Sunday Nov 1 | About.com

    A Swedish study has concluded that rheumatoid arthritis patients did not experience an increased cancer risk in the first 6 years of treatment with TNF blockers .

    Comment?

    Related Topix: Medicine, Arthritis, Health, Rheumatoid Arthritis, Tnf

  7. Study Eases Arthritis Drug Cancer Fears

    Thursday Oct 29 | MedicineNet

    Oct. 29, 2009 -- Rheumatoid arthritis patients who take the biologic drugs Remicade , Humira , and Enbrel do not appear to have an increased risk for developing cancer in the first few years of use, researchers in Sweden report.

    Comment?

    Related Topix: Medicine, Medication, Rochester, MN, Health

  8. Rheumatoid Arthritis Treatment Doesn't Promote CancerRead the original story w/Photo

    Thursday Oct 29 | MedlinePlus

    Treatment with tumor necrosis factor blockers doesn't increase rheumatoid arthritis patients' risk of cancer, new research has found.

    Comment?

    Related Topix: Medicine, Arthritis, Health, Rheumatoid Arthritis, Tnf

  9. Study Eases Arthritis Drug Cancer FearsRead the original story

    Thursday Oct 29 | WebMD Health News Center

    Oct. 29, 2009 - Rheumatoid arthritis patients who take the biologic drugs Remicade , Humira, and Enbrel do not appear to have an increased risk for developing cancer in the first few years of use, researchers in Sweden report.

    Comment?

    Related Topix: Medicine, Medication, Rochester, MN, Health

  10. Anti-Tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In RAPpatientsRead the original story

    Friday Oct 30 | RedOrbit

    A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor therapy.

    Comment?

    Related Topix: Rheumatoid Arthritis, Medicine, Health, Arthritis, Tnf, Sweden, Stockholms, Sweden, Stockholm, Sweden, World News

  11. Eye on Insiders: AmgenRead the original story

    Thursday Oct 29 | The Motley Fool

    Watching insiders is like participating in a weeks-long stakeout. You expect something to happen, but you don't know what.

    Comment?

    Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Drink, Coffee, Johnson and Johnson, Pfizer, Rheumatoid Arthritis, Health

  12. Weighing Pain Relief and Cancer Risk

    Thursday Oct 29 | Time

    During the past decade, a new class of drugs, called TNF inhibitors, has improved the lives of tens of thousands of people who suffer from painful autoimmune diseases including rheumatoid arthritis, psoriatic arthritis, and Crohn's disease.

    Comment?

    Related Topix: Tnf, Medicine, Health, Arthritis, Rheumatoid Arthritis, Crohn's Disease, Health, Psoriatic Arthritis, Medication

  13. Anti-Tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In ...Read the original story

    Thursday Oct 29 | BioSpace

    A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor therapy.

    Comment?

    Related Topix: Medicine, Arthritis, Health, Rheumatoid Arthritis, Tnf, Sweden, Stockholms, Sweden, Stockholm, Sweden, World News

  14. Can curry spice soothe psoriasis?Read the original story

    Wednesday Oct 28 | Whittier Daily News

    Back in the dim days of black-and-white television, one over-the-counter product that was frequently advertised claimed to help "the heartbreak of psoriasis." The phrase is no longer heard in commercials, but the heartbreak is still there.

    Comment?

    Related Topix: Psoriasis, Medicine, Health, Rheumatoid Arthritis, Arthritis

  15. Cephalon Signs Option Agreement To Acquire BioAssets Development ...Read the original story

    Wednesday Oct 28 | BioResearch Online

    Cephalon, Inc. and BioAssets Development Corporation , a privately held biopharmaceutical company, today announced that the companies have signed an agreement that will provide Cephalon with an option to acquire BDC.

    Comment?

    Related Topix: Biotech, Cephalon, Medicine, Healthcare Industry, Tnf, Health, Medication, Pain, West Chester, PA, Chester, PA

  16. Icon_sharepostRead the original story

    Oct 12, 2009 | HealthCentral

    Im getting ready to start Enbrel. Does anyone have comments or suggestions Tom Ensley is getting ready for some changes!! Living With It hello,i am 36.

    Comment?

    Related Topix: Medicine, Medication, Health, Pain

  17. Sustaining Operational Excellence Improvements

    Monday Oct 26 | Biopharm

    Last week, Pfizer, the world's largest biopharmaceutical company, officially completed its merger with Wyeth, which produces some of the world's top-selling medicines, including Enbrel for rheumatoid arthritis and Prevnar, a vaccine against pneumococcal disease.

    Comment?

    Related Topix: Rheumatoid Arthritis, Arthritis, Medicine, Health, Medication

  18. Revolutionary New Treatment for Sciatica Advances in the ClinicRead the original story

    Tuesday Oct 27 | PRWeb

    Chemical inflammation of spinal nerve roots is a major factor in sciatic pain. Chronic and severe sciatica causes widespread disability, and represents a significant unmet medical need.

    Comment?

    Related Topix: Medicine, Medication, 9, Health, Pain, Back Pain

  19. TNF-alpha inhibitors and interleukin inhibitors to drive psoriasis drug market to increase up to $5.2 billion in 2018Read the original story

    Tuesday Oct 27 | Medical News

    Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging TNF-alpha inhibitors and interleukin inhibitors will drive the psoriasis drug market to increase from $3 billion in 2008 to $5.2 billion in 2018 in the United States, France, ...

    Comment?

    Related Topix: Psoriasis, Medicine, Health, Biotech, Tnf, Healthcare Industry, Medication

  20. Cephalon Signs Option To Acquire BioAssetsRead the original story

    Monday Oct 26 | Contract Pharma Breaking News

    Cephalon, Inc. and BioAssets Development Corp. have signed an agreement that will provide Cephalon with an option to acquire BDC.

    Comment?

    Related Topix: Biotech, Cephalon, Medicine, Healthcare Industry, Tnf, Health, Medication, Pain